MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fnut.2026.1729151

Медицинская библиотека · Frontiers in nutrition · 2026

Construction and validation of a nutritional status (CONUT)-based nomogram for predicting prolonged hematological toxicity in relapsed/refractory multiple myeloma after CAR-T cell therapy.

Xu Peng, Duan Xin-Ying, Feng Qi-Wen, Wang Ya-Wen, Liu Yang, Zhang Huan-Xin, Qi Kun-Ming, Li Zhen-Yu, Wu Qing-Yun

СтатьяПеревод в очереди

Аннотация

BACKGROUND AIM: Chimeric antigen receptor (CAR)-T cell therapy is highly effective for relapsed/refractory multiple myeloma (R/R MM). Prolonged hematological toxicity (PHT) is a significant adverse event that adversely affects patient outcomes; however, specific predictive tools are lacking. Our prior study demonstrated that baseline Controlling Nutritional Status (CONUT) affects the prognosis of R/R MM patients receiving CAR-T cell therapy. We aimed to develop and validate a nomogram based on CONUT score for the early prediction of PHT after CAR-T cell therapy.

METHODS

This retrospective study included 302 consecutive patients with R/R MM who received CAR-T cell therapy. Patients were randomly allocated to training and validation cohorts (7:3 ratio). The primary endpoint was prolonged grade 3/4 neutropenia >28 days; predictors were identified using logistic regression. The model's performance was assessed by the area under the curve (AUC), calibration curves, and decision curve analysis (DCA).

RESULTS

Multivariable analysis confirmed four independent predictors for the primary endpoint (prolonged grade 3/4 neutropenia >28 days): high tumor burden (p = 0.013), ferritin (p = 0.002), interferon-γ (IFN-γ, p = 0.018), and CONUT score (p = 0.011). The nomogram built on these factors demonstrated a bias-corrected AUC of 0.815 in the training cohort, which was superior to the CAR-HEMATOTOX model (AUC: 0.706, p < 0.001). The predictive performance remained robust in the internal validation cohort (AUC: 0.824). The calibration curves showed good agreement between prediction and observation, and DCA confirmed the clinical utility of the model. The nomogram also exhibited excellent discriminative ability for predicting a composite PHT endpoint (AUC: 0.821, p = 0.417).

CONCLUSION

We developed a validated nomogram that incorporates the baseline CONUT score and key clinical variables (e.g., tumor burden, ferritin, IFN-γ) to effectively predict PHT risk in R/R MM patients after CAR-T cell therapy, thereby facilitating early risk stratification and guiding personalized management.

Для цитирования: Xu Peng, Duan Xin-Ying, Feng Qi-Wen, Wang Ya-Wen, Liu Yang, Zhang Huan-Xin, Qi Kun-Ming, Li Zhen-Yu, Wu Qing-Yun. Construction and validation of a nutritional status (CONUT)-based nomogram for predicting prolonged hematological toxicity in relapsed/refractory multiple myeloma after CAR-T cell therapy.. Frontiers in nutrition. 2026. DOI: 10.3389/fnut.2026.1729151.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.